Research and Markets (http://www.researchandmarkets.com/research/bbnk2f/parasitic) has announced the addition of the "Parasitic Infection 2016 (28th-30th June 2016)" conference to their offering.

In an academic setting, this event will focus on the current research into parasitic infection and disease.

Over three days, this international summit will cover recent research and developments relating to diagnosis, treatment and drug design. Parasitic infections including malaria and neglected diseases, such as trypanosomiasis, will be discussed in detail, as well as discussion about methods of eradication.

Who should attend?

This event is suited to anyone with an academic or professional interest in parasitic infection and its research; including researchers, senior scientists, postgraduate students, clinicians, pharmacologists, and those who work in research and development of pharmaceuticals and related technology.

Talks Include:

- Natural products as leads to new antiprotozoal drugs

- When peptide chemistry meets antimalarial drug development

- Epidemiological profile of cutaneous leishmaniasis in the province of Taza (Morocco)

- Glimpse of index of infectious parasites incidence in Nigeria: Enugu study

- Natural Products in Drug Developmentand Environmental Control of Malaria

- Conditional inactivation of the Interleukin-1 receptor gene reveals an important role for cytokine regulation during Trichuris muris infection in mice.

- Recent Progress in Structure-Guided Drug Discovery for Parasitic Diseases

- Malaria: situational analysis of prevention and treatment in Africa, with specific reference to South Africa and Cameroon.

- New Tools for Malaria Elimination

- Can the parasitic worm product ES-62 be used to develop drugs for treating allergic and autoimmune diseases?

- The sera from adult patients with signs suggestive of autoimmune diseases present antinuclear autoantibodies

- Point-of-care device for malaria diagnosis and drug resistance status

- Detection of Opisthorchis viverrini Infection in the Rural Community of thailand by Using Korat-Ov Verbal Screening Test and Mini Parasep SF Concentration Technique

- New biomarkers and interventions for severe and cerebral Malaria

- Establishment of chronic infection in malaria involves a novel method of immune evasion

- Schistosomiasis and STH

- NANOHAT: developing a safer and more effective sleeping sickness drug.

- Parasitic agents of infectious diarrhoea: A comparative analysis between rural and urban communities in South Africa.

- Acanthamoeba corneal infection.

- DNA repair in Trypanosoma cruzi: A mechanism of survival and persistence in its hosts

- A chemical drug delivery approach to improve antimalarial activity

- Differential local immune response of the human placanta against the protozoan parasites Trypanosoma cruzi and Toxoplasma gondii

- The parasitic worm immunomodulator ES-62 resets the effector: regulatory B cell balance in inflammatory disease

- The role of mast cell in malaria infection

For more information visit http://www.researchandmarkets.com/research/bbnk2f/parasitic